164 related articles for article (PubMed ID: 35818328)
21. SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
Wei HF; Zhang RF; Zhao YC; Tong XS
Heliyon; 2023 Sep; 9(9):e20184. PubMed ID: 37809412
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of protease-activated receptor-2 (PAR
He S; Xu M; Xiong Z; Hu Y; Huo Q; Lu J; Lin Y; Yang L
J Cell Mol Med; 2021 Feb; 25(3):1415-1424. PubMed ID: 33369107
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
24. Metabolism-associated molecular classification of cervical cancer.
Zhao M; Zhang X; Huan Q; Dong M
BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919
[TBL] [Abstract][Full Text] [Related]
25. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
[TBL] [Abstract][Full Text] [Related]
26. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
27. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
28. Pain-Related Gene Solute Carrier Family 24 Member 3 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma: A Study via Integrated Bioinformatics Analyses and Experimental Verification.
Zhou S; Jin Q; Yao H; Ying J; Tian L; Jiang X; Yang Y; Jiang X; Gao W; Zhang W; Zhu Y; Cao W
Comput Math Methods Med; 2023; 2023():4164232. PubMed ID: 36798148
[TBL] [Abstract][Full Text] [Related]
29. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
30. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
[TBL] [Abstract][Full Text] [Related]
31. Exploring Potential Regulatory Anesthetic Drugs Based on RNA Binding Protein and Constructing CESC Prognosis Model: A Study Based on TCGA Database.
Zheng Y; Meng XW; Yang JP
Front Surg; 2022; 9():823566. PubMed ID: 35449547
[TBL] [Abstract][Full Text] [Related]
32. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
[TBL] [Abstract][Full Text] [Related]
33. S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior
Zhao YC; Wang TJ; She LZ; Cui J; Zhang CH
J Cancer; 2023; 14(15):2931-2945. PubMed ID: 37781076
[No Abstract] [Full Text] [Related]
34. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
Ding H; Zhang L; Zhang C; Song J; Jiang Y
Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
[TBL] [Abstract][Full Text] [Related]
35. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
36. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
37. The role of SLC39A4 in the prognosis, immune microenvironment, and contribution to malignant behavior in vivo and in vitro of cervical cancer.
Zhao YC; Wang TJ; Cui J; She LZ; Zhang RF; Zhang CH
Transl Oncol; 2024 Feb; 40():101839. PubMed ID: 38029507
[TBL] [Abstract][Full Text] [Related]
38. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
40. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]